Envestnet Asset Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$144K Sell
16,318
-12,358
-43% -$109K ﹤0.01% 4296
2025
Q1
$225K Buy
28,676
+851
+3% +$6.66K ﹤0.01% 4088
2024
Q4
$292K Sell
27,825
-32,618
-54% -$343K ﹤0.01% 3905
2024
Q3
$793K Sell
60,443
-2,708
-4% -$35.5K ﹤0.01% 3265
2024
Q2
$888K Buy
63,151
+47,822
+312% +$672K ﹤0.01% 3106
2024
Q1
$259K Buy
+15,329
New +$259K ﹤0.01% 3804
2023
Q3
Sell
-14,214
Closed -$234K 4015
2023
Q2
$234K Sell
14,214
-19,842
-58% -$327K ﹤0.01% 3619
2023
Q1
$11.2K Buy
+34,056
New +$11.2K ﹤0.01% 3945
2022
Q4
Sell
-13,619
Closed -$68K 3951
2022
Q3
$68K Sell
13,619
-26
-0.2% -$130 ﹤0.01% 3786
2022
Q2
$33K Buy
13,645
+202
+2% +$489 ﹤0.01% 3853
2022
Q1
$92K Sell
13,443
-6,065
-31% -$41.5K ﹤0.01% 3813
2021
Q4
$158K Buy
19,508
+6,169
+46% +$50K ﹤0.01% 3699
2021
Q3
$131K Buy
13,339
+23
+0.2% +$226 ﹤0.01% 3561
2021
Q2
$90K Buy
+13,316
New +$90K ﹤0.01% 3573
2020
Q4
Sell
-11,543
Closed -$58K 3272
2020
Q3
$58K Buy
11,543
+688
+6% +$3.46K ﹤0.01% 3053
2020
Q2
$88K Buy
+10,855
New +$88K ﹤0.01% 2994
2019
Q4
Sell
-14,951
Closed -$62K 3081
2019
Q3
$62K Sell
14,951
-207
-1% -$858 ﹤0.01% 2980
2019
Q2
$44K Buy
15,158
+4,259
+39% +$12.4K ﹤0.01% 2997
2019
Q1
$16K Buy
10,899
+262
+2% +$385 ﹤0.01% 2947
2018
Q4
$27K Buy
+10,637
New +$27K ﹤0.01% 2824
2018
Q3
Sell
-1,096
Closed -$7K 1339
2018
Q2
$7K Hold
1,096
﹤0.01% 2598
2018
Q1
$8K Sell
1,096
-427
-28% -$3.12K ﹤0.01% 2528
2017
Q4
$12K Buy
1,523
+1,010
+197% +$7.96K ﹤0.01% 2593
2017
Q3
$5K Sell
513
-26
-5% -$253 ﹤0.01% 2702
2017
Q2
$6K Sell
539
-6
-1% -$67 ﹤0.01% 2792
2017
Q1
$5K Buy
+545
New +$5K ﹤0.01% 2891
2016
Q2
Sell
-1,023
Closed -$11K 3068
2016
Q1
$11K Sell
1,023
-84
-8% -$903 ﹤0.01% 3029
2015
Q4
$14K Sell
1,107
-361
-25% -$4.57K ﹤0.01% 2924
2015
Q3
$24K Buy
+1,468
New +$24K ﹤0.01% 2878